Corcept Therapeutics
CORT
HK$542.77
Share price
1.26%
Change (1 day)
90.24%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Net assets
Net assets on the balance sheet as of March 2025 : HK$5.36 Billion
According to Corcept Therapeutics
's latest financial reports the company has HK$5.36 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $HK$5.27 B | 33.32% |
| 2023-12-31 | $HK$3.95 B | 0.93% |
| 2022-12-31 | $HK$3.92 B | 33.81% |
| 2021-12-31 | $HK$2.93 B | -27.77% |
| 2020-12-31 | $HK$4.05 B | 40.34% |
| 2019-12-31 | $HK$2.89 B | 33.81% |
| 2018-12-31 | $HK$2.16 B | 44.8% |
| 2017-12-31 | $HK$1.49 B | 364.99% |
| 2016-12-31 | $HK$0.32 B | 123.81% |
| 2015-12-31 | $HK$0.14 B | -645.58% |
| 2014-12-31 | $-HK$26.28 Million | -116.12% |
| 2013-12-31 | $HK$0.16 B | -65.97% |
| 2012-12-31 | $HK$0.47 B | 77.13% |
| 2011-12-31 | $HK$0.27 B | 63.52% |
| 2010-12-31 | $HK$0.16 B | -3.49% |
| 2009-12-31 | $HK$0.17 B | 31.11% |
| 2008-12-31 | $HK$0.13 B | 13.73% |
| 2007-12-31 | $HK$0.11 B | 132.25% |
| 2006-12-31 | $HK$49.46 M | -76.01% |
| 2005-12-31 | $HK$0.20 B | -42.26% |
| 2004-12-31 | $HK$0.35 B | -246.37% |
| 2003-12-31 | $-HK$0.25 Billion | 42.58% |
| 2002-12-31 | $-HK$0.18 Billion | -198.07% |
| 2001-12-31 | $HK$0.17 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | HK$613.09 B | 11,331.39% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$136.95 B | 2,453.55% | 🇺🇸 USA |
 Novartis NVS | HK$301.81 B | 5,527.52% | 🇨🇭 Switzerland |
 Eli Lilly LLY | HK$124.38 B | 2,219.21% | 🇺🇸 USA |
 Pfizer PFE | HK$711.42 B | 13,164.89% | 🇺🇸 USA |
 Merck MRK | HK$379.90 B | 6,983.43% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -HK$3.35 Billion | -162.38% | 🇺🇸 USA |
 MannKind Corp MNKD | -HK$0.47 Billion | -108.58% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | HK$45.47 B | 747.88% | 🇺🇸 USA |